Bonita Springs & Naples: 239-235-0380 Jacksonville: 904-800-7380
Text size

News & Articles

Milestones from the forefront of Alzheimer's treatment.

Dr. Samuel Giles appointed to the federal Advisory Council on Alzheimer's Research, Care, and Services

U.S. Department of Health and Human Services Secretary Robert F. Kennedy, Jr. named Memory Treatment Centers co-founder and Chief Medical Officer Dr. Samuel S. Giles one of ten new public members of the Advisory Council on Alzheimer's Research, Care, and Services. Established under the National Alzheimer's Project Act, the council meets quarterly to advise the Secretary on reducing the burden of Alzheimer's disease and related dementias. The full announcement is on hhs.gov.

Oxford Brain Diagnostics and Memory Treatment Centers establish a research collaboration

Oxford Brain Diagnostics and Memory Treatment Centers (Bonita Springs and Jacksonville, Florida) establish a research collaboration to explore Alzheimer's disease in subjects who are cognitively impaired and receiving anti-amyloid treatment, as the global Alzheimer's community enters a new era of drug treatments for Alzheimer's patients.

U.S. FDA grants traditional approval to Leqembi (lecanemab-irmb) for Alzheimer's disease treatment

In a groundbreaking move, Leqembi received traditional approval from the FDA for the treatment of Alzheimer's disease. Memory Treatment Centers continues to offer this therapy to eligible patients.

Memory Treatment Centers featured in the Wall Street Journal

Memory Treatment Centers neurologist Jamie Plante and a current Leqembi patient were interviewed by the Wall Street Journal to investigate availability of new Alzheimer's treatments.

Among the first medical organizations in the United States to offer Leqembi

Memory Treatment Centers, a leading neurocognitive disease clinic, became among the first medical organizations in the United States to offer the innovative Alzheimer's drug Leqembi (lecanemab-irmb).

Memory Treatment Centers applauds U.S. FDA approval of Leqembi (lecanemab)

Memory Treatment Centers is pleased to announce that the Food and Drug Administration approved lecanemab, a new drug for the treatment of Alzheimer's disease.

Schedule your memory evaluation today

Early detection and treatment lead to better outcomes. Time is precious. Time is brain.

Schedule a Visit   Request a Call Back

Bonita Springs & Naples 239-235-0380 Jacksonville 904-800-7380